%0 Journal Article %A Konstantin D. Pandl %A Scott Thiebes %A Manuel Schmidt-Kraepelin %A Ali Sunyaev %T How detection ranges and usage stops impact digital contact tracing effectiveness for COVID-19 %D 2020 %R 10.1101/2020.12.08.20246140 %J medRxiv %P 2020.12.08.20246140 %X To combat the COVID-19 pandemic, many countries have adopted digital contact tracing apps. Various technologies exist to trace contacts that are potentially prone to different types of tracing errors. Here, we study the impact of different proximity detection ranges on the effectiveness and efficiency of digital contact tracing apps. Furthermore, we study a usage stop effect induced by a false positive quarantine. Our results reveal that policy makers should adjust digital contact tracing apps to the behavioral characteristics of a society. Based on this, the proximity detection range should at least cover the range of a disease spread, and be much wider in certain cases. The widely used Bluetooth Low Energy protocol may not necessarily be the most effective option in its current setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is partially funded by the German Research Foundation (DFG). Grant number: DFG SU 717/15-1Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe paper (with the supplementary material) describes the research method, and the source code for the simulation is linked to GitHub. https://github.com/kpandl/COVID-19-contact-tracing-simulation %U https://www.medrxiv.org/content/medrxiv/early/2020/12/11/2020.12.08.20246140.full.pdf